Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
 

 

TTD Drug ID: DAP000300

Drug Information
NamePrazosin    
SynonymsPrazosina; BCBcMAP01_000227; HMS2089G09; Prestwick0_000947; IDI1_002113; Quinazoline, 4-amino-6,7-dimethoxy-2-(4-(2-furoyl)piperazin-1-yl)-; 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)piperazine; Spectrum5_001365; 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl) piperazine; Prazosina [INN-Spanish]; BSPBio_001036; [4-(4-amino-6,7-dimethoxy-quinazolin-2-yl)piperazin-1-yl]-(2-furyl)methanone; Minipress (TN); NCI60_002417; TNP00312; STK301545; KBioSS_000376; CAS-19237-84-4; 1-(3-Amino-6,7-dimethoxy-2- quinazolinyl)-4-(2-furanyl-carbonyl)piperazine hydrochloride; DB00457; C07368; 2-[4-(2-furoyl)piperazin-1-yl]-6,7-dimethoxyquinazolin-4-amine; Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furoyl)-; L000666; Justac; KBioGR_000376; KBio2_002944; BPBio1_001006; 19216-56-9; NCGC00024324-08; Spectrum4_000483; NCGC00016740-01; HMS1990D17; Furazosin; Spectrum_000822; Bio1_000365; NCGC00016740-14; SPBio_001297; Oprea1_314778; NINDS_000375; KBio3_000731; KBioGR_000965; Prazosinum; Prestwick2_000947; KBio2_003870; Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)- (9CI); C19H21N5O4; CHEMBL2; 4-(4-Amino-6,7-dimethoxyquinazolin-2-yl)piperazinyl 2-furyl ketone; BRD-K49111258-001-02-8; KBio2_000376; Prazosine [INN-French]; NCGC00024324-02; IDI1_000375; NCGC00024324-04; AB00053528; [4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(furan-2-yl)methanone; prazosin; Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)-; KBio2_005512; BSPBio_002221; Bio1_001343; HMS1362D17; Lentopres; CHEBI:8364; BRD-K49111258-003-05-7; KBio3_000732; SMP1_000063; D08411; Prazosine; BSPBio_000914; HSDB 3298; NCGC00024324-07; NCGC00024324-05; Prazosinum [INN-Latin]; BRN 0768345; TL8001573; CID4893; NCGC00016740-02; NCGC00024324-09; Bio2_000358; AC1L1J6T; [4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl](furan-2-yl)methanone; SPBio_003073; 2-(4-(2-Furoyl)piperazin-1-yl)-4-amino-6,7-dimethoxyquinazoline; AKOS000310009; KBio1_000375; CP-12299; EINECS 242-885-8; Tocris-0623; HMS1792D17; KBioSS_001302; [3H]-Prazosin; MolPort-000-891-036; Prazosin [INN:BAN]; NCGC00024324-06; Prazosin (INN); Prestwick3_000947; 5-25-13-00365 (Beilstein Handbook Reference); Spectrum2_001289; LS-140002; Prazosin HCl; Prazocin; Bio1_000854; ZINC00601304; NCGC00016740-03; KBio2_001302; Spectrum3_000551; Bio2_000838; DivK1c_000375; ST075549; Prestwick1_000947; UNII-XM03YJ541D; Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furoyl)- (8CI); KBio3_001721; KBio2_006438    
Trade NameMinipress;Vasoflex; Hypovase    
CompanyPfizer Pharmaceuticals    
IndicationHypertensionApproved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
   
Therapeutic ClassAntihypertensive Agents    
CAS NumberCAS 19216-56-9
FormularC19H21N5O4    
PubChem Compound IDCID 4893.    
PubChem Substance IDSID 9572.    
ChEBI8364;    
SuperDrug ATC IDC02CA01;    
SuperDrug CAS ID019216569;    
TargetAlpha-1 adrenergic receptorAntagonist[2][3]
Ref 1FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (ANDA) 071745 To Reference
Ref 2Adventitia removal does not modify the alphaID-adrenoceptors response in aorta during hypertension and ageing. Auton Autacoid Pharmacol. 2009 Jul;29(3):117-33. To Reference
Ref 3Characterization of alpha-adrenoceptor subtypes in smooth muscle of equine ileum. Am J Vet Res. 2001 Sep;62(9):1370-4. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

 
   
           
 
Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543